| Product Code: ETC6771643 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Parkinsons Disease Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Parkinsons Disease Market - Industry Life Cycle |
3.4 Colombia Parkinsons Disease Market - Porter's Five Forces |
3.5 Colombia Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Colombia Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Colombia Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Colombia Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Colombia Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Colombia Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of Parkinson's disease in Colombia |
4.2.2 Advancements in treatment options and technologies for Parkinson's disease |
4.2.3 Growing geriatric population in Colombia leading to higher prevalence of Parkinson's disease |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas of Colombia |
4.3.2 High cost of Parkinson's disease medications and treatments |
4.3.3 Lack of comprehensive government policies and support for Parkinson's disease management |
5 Colombia Parkinsons Disease Market Trends |
6 Colombia Parkinsons Disease Market, By Types |
6.1 Colombia Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Colombia Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Colombia Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Colombia Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Colombia Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Colombia Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Colombia Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Colombia Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Colombia Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Colombia Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Colombia Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Colombia Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Colombia Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Colombia Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Colombia Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Colombia Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Colombia Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Colombia Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Colombia Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Colombia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Colombia Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Colombia Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Colombia Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Colombia Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Colombia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Colombia Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Colombia Parkinsons Disease Market Export to Major Countries |
7.2 Colombia Parkinsons Disease Market Imports from Major Countries |
8 Colombia Parkinsons Disease Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of Parkinson's disease |
8.2 Number of healthcare facilities offering specialized Parkinson's disease care in Colombia |
8.3 Percentage of Parkinson's disease patients receiving appropriate treatment and therapy |
8.4 Patient satisfaction scores with Parkinson's disease management services |
8.5 Number of research studies and clinical trials focused on Parkinson's disease in Colombia |
9 Colombia Parkinsons Disease Market - Opportunity Assessment |
9.1 Colombia Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Colombia Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Colombia Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Colombia Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Colombia Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Colombia Parkinsons Disease Market - Competitive Landscape |
10.1 Colombia Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Colombia Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here